Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Pennant International ( (GB:PEN) ) has issued an announcement.
Pennant International Group PLC announced that it has 47,557,533 Ordinary Shares in issue, all with equal voting rights, as part of its compliance with the FCA’s Disclosure Guidance and Transparency Rules. This announcement is crucial for shareholders to determine their interests in the company’s share capital, reflecting Pennant’s strategic focus on sustainable revenue growth amid increasing demand for its high-margin software and services in regulated industries.
The most recent analyst rating on (GB:PEN) stock is a Sell with a £21.00 price target. To see the full list of analyst forecasts on Pennant International stock, see the GB:PEN Stock Forecast page.
Spark’s Take on GB:PEN Stock
According to Spark, TipRanks’ AI Analyst, GB:PEN is a Underperform.
Pennant International’s overall stock score is primarily impacted by its weak financial performance and bearish technical indicators. The negative P/E ratio further detracts from its valuation appeal. Improving profitability and reversing the bearish trend are crucial for enhancing the stock’s outlook.
To see Spark’s full report on GB:PEN stock, click here.
More about Pennant International
Pennant International Group plc is a technology-driven global provider of system support software and services, technical services, and training solutions. The company serves key markets such as Aerospace, Defence, Rail, Shipping, Nuclear, and Space, focusing on sustainable recurring and repeatable revenues. It operates through three business segments: Auxilium software, Technical Services, and Training Systems, aiming to maximize operational efficiency and profitability growth.
Average Trading Volume: 94,819
Technical Sentiment Signal: Sell
Current Market Cap: £10.08M
Find detailed analytics on PEN stock on TipRanks’ Stock Analysis page.